Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin

15 gennaio 2021 aggiornato da: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

PATIENT-REPORTED-OUTCOMES IN CHRONIC CERVICAL PAIN PATIENTS WITH ACCOMPANYING UPPER LIMB RADIATING PAIN (NEUROPATHIC COMPONENT) TREATED WITH PREGABALIN IN PRIMARY CARE SETTINGS

The purpose of this study is to evaluate the effect of pregabalin on patient reported outcomes compared with conventional analgesic care in chronic cervical pain patients with accompanying upper limb radiating pain (neuropathic component) treated in primary care settings under routine clinical practice.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Rational and background:

Cervical pain with upper limb radiating pain(neuropathic component), such as cervical spondylosis radiculopathy or cervical spondylotic myelopathy, is one of the typical and common neuropathic pain. However, in Japan, large number of those patients are treated with NSAIDs without adequately assessing the cause of pain, despite that α2δ ligand, SNRI (Serotonin and Norepinephrine Reuptake Inhibitors ), and TCA (Tricyclic Antidepressants) are recommended in the clinical guidelines for neuropathic pain. Therefore, treatment satisfaction of these patients is low. This is currently a major issue in treatment for cervical pain with neuropathic component in Japan. In fact, our previous study which assessed the effect of pregabalin in low back pain patients with radiculopathy suggested that the selection of appropriate analgesics according to the cause of pain improved pain related sleep interference, pain and function. However, there are a few reports with regard to effect of pregabalin in cervical pain patients with neuropathic component. Therefore, we propose to conduct an observational study in order to assess the effects of pregabalin in cervical radiculopathy, when added to routine clinical care. The present study can encourage an understanding of the necessary of assessing cause of the pain, and treating with appropriate analgesics.

Research objectives :

To evaluate the effect of pregabalin comparing with the conventional analgesic care in chronic cervical pain patients with accompanying upper limb radiating pain(neuropathic component) treated in primary care settings under routine clinical practice.

Study design:

This is an 8-week, multicenter prospective non-interventional observational study. Subjects who have chronic cervical radiating pain patients with accompanying upper limb radiating pain (with a neuropathic component) and meet all other entry criteria are enrolled at baseline in the duration of study. Study arms are pregabalin with or without usual care vs. usual care (mono/combo therapy). The usual care are assumed NSAIDs, Antidepressants, weak opioids, acetaminophen etc.

The analgesic treatment is determined by the clinical judgment of the physician in charge of patient management. This therapeutic choice is not related to the decision to take part in the study. All enrolled subjects will be received with analgesic treatment. The study requires 3 visits at least, baseline/enrollment visit, Week 4 visit and Week 8 visit (or discontinuation).

Tipo di studio

Osservativo

Iscrizione (Effettivo)

369

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Giappone
      • Fukusima, Giappone, 960-8251
        • Fukushima Daiichi Hospital
      • Saga, Giappone, 840-8571
        • Saga-Ken Medical Center Koseikan
      • Tokyo, Giappone, 104-0031
        • Tokyo Rheumatism Pain Clinic
    • Chiba
      • Ichikawa, Chiba, Giappone, 272-0021
        • Satoh Orthopaedic Clinic
      • Ichikawa, Chiba, Giappone, 272-0138
        • Shiraishi Orthopaedic Clinic
    • Fukuoka
      • Fukuoka-shi, Fukuoka, Giappone, 813-8501
        • Chihaya Hospital
      • Fukuokashi, Fukuoka, Giappone, 810-0022
        • Clinic for Sports Medicine and Nutrition
      • Fukuokashi, Fukuoka, Giappone, 812-0041
        • Seiwa Orthopedics Surgery Internal Medicine
      • Fukuokashi, Fukuoka, Giappone, 812-0046
        • Kiheikai Yoh Orthopedic Clinic
      • Higashi-ku,Fukuoka, Fukuoka, Giappone, 813-0017
        • Fukuoka Mirai Hospital
      • Kitakyusyu-shi, Fukuoka, Giappone, 800-0057
        • Shin Komonji Hospital
    • Gunma
      • Takasaki-shi, Gunma, Giappone, 370-0035
        • Takasaki Pain Clinic
    • Hokkaido
      • Sapporoshi, Hokkaido, Giappone, 064-8570
        • Miyanomori Memorial Hospital
    • Hyogo
      • Himeji-shi, Hyogo, Giappone, 670-0976
        • Oomuro Orthopedic Clinic
      • Kako-gun, Hyogo, Giappone, 675-1115
        • Oonishi Medical Clinic
      • Kobe, Hyogo, Giappone, 657-0824
        • Watanabe Orthopaedic Clinic
    • Kanagawa
      • Fujisawa-shi, Kanagawa, Giappone, 252-0802
        • Fujisawa Shonandai Hospital
      • Kawasakishi, Kanagawa, Giappone, 213-0001
        • Ando Orthopaedics Hospital
      • Sagamiharashi, Kanagawa, Giappone, 252-5225
        • General Sagami Kosei Hospital
      • Saitama, Kanagawa, Giappone, 356-0004
        • Arai Orthopaedic Clinic
      • Yamato-shi, Kanagawa, Giappone, 242-0024
        • Saitoh Orthopedic Sports Clinic
    • Saitama
      • Ageo, Saitama, Giappone, 362-0021
        • Ageo Medical Clinic
    • Tokyo
      • Adachi, Tokyo, Giappone, 120-0033
        • Nakaicho Clinic
      • Chuo, Tokyo, Giappone, 104-0031
        • Kyobashi Orthopaedic Clinic
      • Edogawa, Tokyo, Giappone, 133-0057
        • Morishima Clinic
      • Katsushika, Tokyo, Giappone, 124-0024
        • Shinkoiwa Ekimae Sogo Clinic
      • Meguro, Tokyo, Giappone, 152-0002
        • Meguro Seikeigeka Naika
      • Meguro, Tokyo, Giappone, 153-0065
        • Meguro Yuai Clinic
      • Ohta, Tokyo, Giappone, 145-0066
        • Takemoto Orthopaedic Clinic
      • Shinagawa, Tokyo, Giappone, 140-0014
        • Ohimachi Orthopaedic Clinic
      • Shinnzyuku, Tokyo, Giappone, 169-0073
        • Shinjuku Research Park Clinic
      • Suginami, Tokyo, Giappone, 166-0003
        • Kouenji Orthopedic Clinic
      • Toshima, Tokyo, Giappone, 171-0033
        • Daido Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

20 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Chronic cervical pain patients with accompanying upper limb radiating pain (neuropathic component) treated with pregabalin or other analgesics

Descrizione

Inclusion Criteria:

Subject who received the enough study information and signed informed consent form.

Subject who had chronic pain with accompanying radiating pain to the superior limb beyond the elbow.

Subject is male or female patient ≧20 years old. Subject who reported neck pain with accompanying radiating pain to superior limb (12 weeks or greater in duration at Visit 0).

Subject who is refractory to previous analgesics for 12 weeks and more. Subject who is able and willing to complete all study related assessment tools and complied with scheduled clinic visits and clinical study procedures.

Subject whose pain NRS ≧5 and PRSIS ≧1 at baseline (based on recall over the past week).

Exclusion Criteria:

Subject who, in the opinion of the investigator, was not likely to complete the trial for whatever reason.

Subject who was treated with Pregabalin within the past 12 weeks (on baseline). Subject who has been regularly treated cervical pain with nerve blocks (such as stellate ganglion block, epidural block, radicular block and trigger point injection etc.).

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Pregabalin / Other analgesics
Patients will be treated for 8 weeks with pregabalin in primary care: no intervention
Altro: No Intervention
The study is observational.
Other analgesics
Patients will be treated for 8 weeks with other analgesics in usual care: no intervention
Altro: No Intervention
The study is observational.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline at 8 weeks in Pain Related Sleep Interference Scale (PRSIS - Past Week Recall)
Lasso di tempo: Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
The Pain Related Sleep Interference Scale (past week recall) consists of an 11-point numeric rating scale (NRS) ranging from 0 (pain did not interfere with sleep) to 10 (pain completely interfered with sleep). Subjects are to describe how their pain has interfered with their sleep during the past week by choosing the appropriate number between 0 and 10.
Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline in Neck Disability Index (NDI)
Lasso di tempo: Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
The Neck Disability Index (NDI) is an index of how well patients with cervical pain are able to function with regard to daily activities. The score for the index ranges from 0 to 50 with a lower score indicating better function. In the event that a patient has used rescue medication within 12 hours of the clinic visit, the patient should respond to the questions based on their functional ability in the 24 hour period just preceding the use of rescue medication.
Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
Change From Baseline in Pain Numeric Rating Scale (Pain NRS - past week recall)
Lasso di tempo: Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
The Pain NRS (past week recall) consists of an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (worst possible pain). Subjects are asked to describe their average pain during the past week by choosing the appropriate number between 0 and 10.
Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
Change From Baseline in Euro Qol- 5 Dimensions -5 Level (EQ-5D-5L)-QOL-Score-
Lasso di tempo: Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)

The EQ-5D-5L is a copyrighted, subject-completed questionnaire designed to assess health-related quality of life in terms of a single index value or utility score. There are two components to the EQ-5D-5L: A Health State Profile and a Visual Analogue Scale (VAS). Recent guidance suggests that the Health State Profile and VAS should be administered together.

The Health State Profile is designed to record the subject's level of current health for five domains comprising a health profile: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Responses from the five domains are used to calculate a single utility index value.
Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
Change From Baseline in Euro Qol- 5 Dimensions -5 Level (EQ-5D-5L)-Visual Analogue Scale -
Lasso di tempo: Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)

The EQ-5D-5L is a copyrighted, subject-completed questionnaire designed to assess health-related quality of life in terms of a single index value or utility score. There are two components to the EQ-5D-5L: A Health State Profile and a Visual Analogue Scale (VAS). Recent guidance suggests that the Health State Profile and VAS should be administered together.

The Visual Analogue Scale (VAS) is designed to rate the subject's current health state on a scale from 0 to 100 where 0 represents the worst imaginable health state and 100 represents the best imaginable health state.
Baseline, Visit 2 (week 4), Final visit (week 8 or discontinuation)
Clinical Global Impression of Change (CGIC)
Lasso di tempo: Final visit (week 8 or discontinuation)
The CGIC assessment includes one question (1-7 scale) inquiring about the subject's improvement considering their current disease state.
Final visit (week 8 or discontinuation)
Patient Global Impression of Change (PGIC)
Lasso di tempo: Final visit (week 8 or discontinuation)
The PGIC is a subject-rated instrument that measures change in the subject's overall status on a 7-point scale. Scores range from 1 (very much improved) to 7 (very much worse).
Final visit (week 8 or discontinuation)
Work Productivity and Activity Impairment Questionnaire: (WPAI: GH)
Lasso di tempo: Final visit (week 8 or discontinuation)
The WPAI: GH is a self-administered questionnaire that measures the effect of general health and symptom severity on work productivity and regular activities. Unlike general health or disease-specific measures, the WPAI:GH assesses function-related endpoints to allow a measure of the economic impact of relative differences in either the safety or efficacy of therapeutic endpoints. In this study, the WPAI: GH will measure the effect of the patient's chronic cervical pain with accompanying upper limb pain (neuropathic component) on work productivity and regular activities.
Final visit (week 8 or discontinuation)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 ottobre 2016

Completamento primario (Effettivo)

24 ottobre 2017

Completamento dello studio (Effettivo)

24 ottobre 2017

Date di iscrizione allo studio

Primo inviato

9 agosto 2016

Primo inviato che soddisfa i criteri di controllo qualità

11 agosto 2016

Primo Inserito (Stima)

16 agosto 2016

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 gennaio 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 gennaio 2021

Ultimo verificato

1 gennaio 2019

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • A0081354

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Dolore cervicale

Prove cliniche su No Intervention

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Philippines

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi